PRISMA: A pan-European co-ordinating action to advance the science in end-of-life cancer care
PRISMA: A pan-European co-ordinating action to advance the science in end-of-life cancer care
复制标题
DOI：
10.1016/j.ejca.2010.01.035
复制
发表时间：
2010-06-01
影响因子：
8.4
通讯作者：
Higginson, Irene J.
中科院分区：
文献类型：
--
作者：
Harding, Richard;Higginson, Irene J.
简介：欧洲进行性癌症的流行病学和相关死亡率强调了其公民对高质量姑息治疗和临终关怀的必要性。目前，对临终病人的护理研究不足，资金不足。这是由于缺乏优先顺序，定义生命终末期的挑战，缺乏欧洲共同的研究战略来确定和实施最佳实践和最高科学原则，以及需要共同使用适当的经过充分验证的工具来衡量和改善欧洲的生命终末期癌症体验。方法：PRISMA是一个由欧盟委员会框架计划7资助的泛欧协调行动。它与9个国家的12个合作伙伴一起，正在提供一系列8个工作包，其共同目标是促进衡量临终关怀的最佳实践，制定反映欧洲文化多样性的议程和指导，并了解公共和临床优先事项。核心工具的选择、调整和使用指南由公共卫生和临床研究专家提供信息。讨论：PRISMA目前正在制作一系列成果，供更广泛的研究人员、决策者、资助者和临床医生使用。我们鼓励建立新的伙伴关系，以PRISMA的工作为基础，并根据我们的交付成果领导高质量的工作。我们希望PRISMA能够解决目前整个欧洲癌症临终研究缺乏协调的问题，并将促进反映欧洲人口和优先事项的循证护理的实施。(C)2010爱思唯尔有限公司保留所有权利。
Introduction: The epidemiology of progressive cancer and associated mortality in Europe underlines the essential need for high quality palliative and end-of-life care for its citizens. Currently, care of patients at the end-of-life is under-researched and under-funded. This is due to a lack of prioritisation, challenges in defining end-of-life, lack of a common research strategy for Europe that identifies and implements best practice and highest scientific principles, and the need for common use of appropriate well-validated tools to measure and improve the end-of-life cancer experience in Europe.Methods: PRISMA is a pan-European co-ordinating action funded under Framework Programme 7 of the European Commission. With 12 partners in 9 countries, it is delivering a series of 8 Work Packages with the common aim of promoting best practice in the measurement of end-of-life care, setting an agenda and guidance that reflects European cultural diversity, and is informed by both public and clinical priorities. Guidance in the selection, adaptation and use of core tools is informed by experts in public health and clinical research.Discussion: PRISMA is currently producing a series of outputs to be accessible to the wider community of researchers, policy makers, funders and clinicians. We encourage new partnerships to build on the work of PRISMA and to lead high quality work informed by our deliverables. PRISMA, we hope, is redressing the current lack of co-ordination of cancer end-of-life research across Europe, and will catalyse the conduct of evidence-based care that reflects European populations and priorities. (C) 2010 Elsevier Ltd. All rights reserved.